Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Angiosarcoma
NCT00288015Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 2005
- Primary completion
- Jun 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in angiosarcoma, sponsored by Northwestern University. Started Oct 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on NCT00288015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288015.